TNNT2 and myocardial infarction: The administration of thrombolytic agents for pharmacological lysis has become a standard treatment approach for those suffering from acute myocardial infarction [15]. Cardiac troponin T (cTnT) is recognized as the most reliable biomarker for diagnosing ST-segment elevation myocardial infarction (STEMI).